We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Blood Test Detects Tumor Markers Using Laser-Stimulated Fluorescence

By LabMedica International staff writers
Posted on 09 Apr 2014
Print article
Image: The concentration of biological molecules in a sample can be observed visually using laser-stimulated fluorescence (Photo courtesy of Fraunhofer IPA).
Image: The concentration of biological molecules in a sample can be observed visually using laser-stimulated fluorescence (Photo courtesy of Fraunhofer IPA).
Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously involving highly specific proteins.

An increased concentration in the blood provides one indication of the disease for physicians, but it has been quite expensive in time and effort to detect the markers thus far and to be able to detect a single specific one, scientists must first separate and purify the blood in several steps and then isolate the marker.

Scientists at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA (Mannheim, Germany) have developed a one-step analysis to detect tumor biomarkers. The difficulty in detecting specific molecules in the blood or urine lies in the enormous number of substances that are mixed in the sample. They cause a high level of background noise that masks the desired signal and the signal from the protein being searched for can no longer be distinguished.

To improve the signal to noise ratio, the scientists used magnetic beads, which are particles only a few micrometers in size that have a magnetic core. If a magnet is positioned externally on the test tube, the beads can be arrested or steered. This technique is already in use. To isolate molecules from a solution like blood, the surface of the beads with were coated with specialized antibodies. The proteins that are being searched for wind past the beads, and the antibodies attach to them. If the magnet is held to the outside of the test tube, the beads together with the desired proteins stick to the interior surface of the tube, while the rest of the solution can be easily removed.

Additional means were developed with the samples exposed to the coated beads, but also to additional antibodies that have fluorescent markers bound to them. These antibodies attach themselves to the proteins being searched for and cause them to fluoresce. The optical signal is very weak though, and would normally disappear in the background noise. When using an alternating magnetic field, the magnetic beads flock together in rhythm, and the fluorescent markers bound to the surfaces emit their light in synchrony and radiate considerably more brightly than any given bead by itself. The advantage of this visualization technique is that the optical signal provides immediate insight about whether a tumor marker protein is present in the blood. The analysis equipment was presented at the Analytica international trade fair held April 1–4, 2014, in Munich (Germany).

Related Links:

Fraunhofer Institute for Manufacturing Engineering and Automation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.